Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3426 Target Snapshot

5-hydroxytryptamine receptor 5A · SINGLE PROTEIN · Homo sapiens

1,475Compounds
287Assays
14Approved Drugs
893.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P47898. Use UniProt P47898 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P47898 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 5A as ChEMBL target CHEMBL3426, mapped to UniProt P47898. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 5A
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3426
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P47898
5-hydroxytryptamine receptor 5A
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 5A is the right protein anchor across sources, using UniProt P47898 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 5A
UniProt AccessionP47898
Component TypeProtein
Sequence Length357 aa

5-hydroxytryptamine receptor 5A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 5A, mapped to UniProt P47898. Sequence length is 357 aa.

Mapped IDP47898
Review name5-hydroxytryptamine receptor 5A
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

14
Approved
4
Phase III
11
Phase II
Assay Mix

Activity Type Distribution

IC5057.0
KI601.0
EC50231.0
KD4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3654198 9.17 Ki 0.68 Preclinical
CHEMBL3654206 9.12 Ki 0.75 Preclinical
CHEMBL282199 9.11 Ki 0.78 Preclinical
CHEMBL3654212 9.07 Ki 0.85 Preclinical
CHEMBL3654208 9.06 Ki 0.88 Preclinical
CHEMBL3654214 9.02 Ki 0.95 Preclinical
CHEMBL1210154 9.0 IC50 1.0 Preclinical
CHEMBL93240 9.0 Ki 1.0 Clinical
CHEMBL3654199 8.96 Ki 1.1 Preclinical
CHEMBL3654197 8.96 Ki 1.1 Preclinical
Distribution

pChEMBL Value Distribution

48
5.0
77
5.5
72
6.0
81
6.5
36
7.0
33
7.5
37
8.0
25
8.5
9
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

BREXPIPRAZOLE
CHEMBL2105760
Approved 2015
CINACALCET HYDROCHLORIDE
CHEMBL1200776
Approved 2004
TEGASEROD MALEATE
CHEMBL1516474
Approved 2002
ARIPIPRAZOLE
CHEMBL1112
Approved 2002
RISPERIDONE
CHEMBL85
Approved 1993
SUMATRIPTAN
CHEMBL128
Approved 1992
CLOZAPINE
CHEMBL42
Approved 1989
PRAZOSIN HYDROCHLORIDE
CHEMBL1558
Approved 1976
ERGOTAMINE
CHEMBL442
Approved 1948
DIHYDROERGOTAMINE MESYLATE
CHEMBL1200517
Approved 1946
Assay Landscape

Assay Landscape

287
Total Assays
371
Tested Compounds
3
Assay Types
Binding — 272 assays, 371 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 215 210 6.5
cell-based format 55 145 7.0
assay format 2 16 6.4
Functional — 12 assays, 10 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 7 8 5.6
assay format 5 2 8.0
ADME — 3 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 0
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine